Cerus (CERS) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Cerus (CERS) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -6.18% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 66.99% |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 93.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.18% |
| Dec 31, 2025 | 53.76% |
| Sep 30, 2025 | 237.17% |
| Jun 30, 2025 | 3.30% |
| Mar 31, 2025 | 22.33% |
| Dec 31, 2024 | -261.19% |
| Sep 30, 2024 | 80.83% |
| Jun 30, 2024 | 69.15% |
| Mar 31, 2024 | 59.30% |
| Dec 31, 2023 | -95.12% |
| Sep 30, 2023 | 58.13% |
| Jun 30, 2023 | -5.26% |
| Mar 31, 2023 | -22.97% |
| Dec 31, 2022 | 272.07% |
| Sep 30, 2022 | 39.11% |
| Jun 30, 2022 | 52.89% |
| Mar 31, 2022 | 57.83% |
| Dec 31, 2021 | -115.78% |
| Sep 30, 2021 | 42.14% |
| Jun 30, 2021 | 31.55% |